Showing 11 - 20 of 124
Persistent link: https://www.econbiz.de/10005260434
Persistent link: https://www.econbiz.de/10010557255
Persistent link: https://www.econbiz.de/10010845437
Persistent link: https://www.econbiz.de/10010863557
Persistent link: https://www.econbiz.de/10007105949
Persistent link: https://www.econbiz.de/10008046581
Persistent link: https://www.econbiz.de/10009869188
In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had received approval several...
Persistent link: https://www.econbiz.de/10014170599
Karen Levy and her colleague, Margaret Ndanyi, learn the results of their nation-wide effort to rid Kenyan school children of parasitic worm infection. Learning Objective: To share results a program described in the A case
Persistent link: https://www.econbiz.de/10014170607
Karen Levy and her colleague, Margaret Ndanyi, have spent the last six months planning and preparing for a national Kenyan program to target school children most at risk for parasitic worm infection. One week after its launch, the program seemed to be going well but Ndanyi and Levy knew that it...
Persistent link: https://www.econbiz.de/10014170608